上市更进一步 甘露藏药吸引多家实力机构战略投资

Core Insights - The strategic investment initiative by Gansu Tibetan Medicine Co., Ltd. marks a significant step towards achieving its listing goals and implementing the "Galsang Flower Action" plan [1] Group 1: Investment and Strategic Partnerships - Gansu Tibetan Medicine successfully introduced four strong strategic investors, reflecting the market's high recognition of the company's future development potential [1] - The company aims to raise approximately 174 million yuan through this fundraising, leveraging the advantages of strategic shareholders in capital, industry, channels, and management to enhance its core competitiveness [1] - The strategic investors include a national-level fund focused on mixed-ownership reform, a private equity fund affiliated with Guangzhou Pharmaceutical Group, a local government-backed private equity fund in Chengdu, and a financial institution controlled by the Tibet Autonomous Region [2] Group 2: Market Expansion and Development Strategy - Gansu Tibetan Medicine is focusing on expanding its presence in mainland markets, particularly targeting Beijing, the Yangtze River Delta, and Southwest regions for future market development [1] - The collaboration with capable partners is expected to lay a solid foundation for the strategic development of Tibetan medicine across the nation [1] - The strategic investors expressed confidence in the company's growth prospects and plan to actively participate in governance and strategic planning to enhance market competitiveness [3]